Home > Boards > US Listed > Medical - Healthcare > HealthSouth (HLS)

Very interesting...how has this lawsuit effected the stock

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
jme-rocks-stocks Member Profile
 
Followed By 60
Posts 4,413
Boards Moderated 0
Alias Born 11/24/08
160x600 placeholder
HLS Therapeutics Announces Promotional Agreement with Pfizer for Vascepa® in Canada PR Newswire (Canada) - 8/16/2021 6:30:00 AM
HLS Therapeutics Announces Second Quarter Fiscal 2021 Financial Results PR Newswire (Canada) - 8/5/2021 6:30:00 AM
HLS Therapeutics to Present at the Canaccord Genuity 41st Annual Growth Conference PR Newswire (Canada) - 8/4/2021 6:30:00 AM
HLS Therapeutics to Host Q2 2021 Financial Results Conference Call PR Newswire (Canada) - 7/22/2021 6:30:00 AM
HLS Therapeutics Reports Annual Meeting Results PR Newswire (Canada) - 6/18/2021 4:15:00 PM
HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on June 16, 2021 PR Newswire (Canada) - 6/15/2021 6:30:00 AM
HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on June 10, 2021 PR Newswire (Canada) - 6/9/2021 6:30:00 AM
HLS Therapeutics Announces Participation at Upcoming Investor Conferences PR Newswire (Canada) - 5/26/2021 6:30:00 AM
HLS Therapeutics Announces First Quarter Fiscal 2021 Financial Results PR Newswire (Canada) - 5/6/2021 6:30:00 AM
HLS Therapeutics to Host Q1 2021 Financial Results Conference Call PR Newswire (Canada) - 4/22/2021 6:30:00 AM
HLS Therapeutics Announces Participation in Upcoming Conferences PR Newswire (Canada) - 4/15/2021 6:30:00 AM
HLS Therapeutics Comments on Rule Enacted by Quebec Health Minister Christian Dubé and the Absence of an Exception for New R... PR Newswire (Canada) - 4/1/2021 6:30:00 AM
HLS Therapeutics Announces that Icosapent Ethyl (Vascepa®) is Included in the 2021 Canadian Cardiovascular Society (CCS) Gui... PR Newswire (Canada) - 3/29/2021 6:30:00 AM
HLS Therapeutics Announces Fourth Quarter and Fiscal 2020 Financial Results PR Newswire (Canada) - 3/18/2021 6:30:00 AM
HLS Therapeutics Announces that VASCEPA® (Icosapent Ethyl) is Found in Prespecified and Post Hoc Analyses to Significantly R... PR Newswire (Canada) - 3/17/2021 11:34:00 AM
HLS Therapeutics to Host Q4 and Fiscal 2020 Financial Results Conference Call PR Newswire (Canada) - 3/4/2021 6:30:00 AM
HLS Therapeutics to Participate in Upcoming Virtual Non-Deal Roadshow on February 25, 2021 PR Newswire (Canada) - 2/23/2021 6:30:00 AM
HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on February 18, 2021 PR Newswire (Canada) - 2/16/2021 4:30:00 PM
HLS Therapeutics Provides Update on Private and Public Payer Reimbursement for Vascepa® PR Newswire (Canada) - 2/16/2021 6:30:00 AM
VASCEPA® (Icosapent Ethyl) Receives Further Inclusions in Guidelines from International Medical Societies for its Role in Re... PR Newswire (Canada) - 1/28/2021 6:30:00 AM
HLS Therapeutics Announces Final Redemption of Preferred Shares PR Newswire (Canada) - 1/4/2021 6:30:00 AM
HLS Therapeutics Announces Board Appointment PR Newswire (Canada) - 12/21/2020 6:30:00 AM
HLS Therapeutics Announces Update on Health Canada Filings for MyCare and Trinomia PR Newswire (Canada) - 12/16/2020 6:30:00 AM
HLS Therapeutics Reports Efficacy and Safety Results from Pilot Study Treating COVID-19 Infected Outpatients with Vascepa® (... PR Newswire (Canada) - 12/14/2020 6:30:00 AM
HLS Therapeutics Establishes Automatic Share Purchase Plan PR Newswire (Canada) - 11/19/2020 6:30:00 AM
jme-rocks-stocks   Friday, 06/19/09 07:32:43 PM
Re: scion post# 590
Post # of 599 
Very interesting...how has this lawsuit effected the stock in this company?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences